EDWARDS LIFESCIENCES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.72 USD | -0.80% |
|
+1.72% | +13.73% |
Presenter SpeechMark Wilterding (Executives)Well, thanks, everyone, for joining us. I know it'...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.72
USD
Average target price
95.27
USD
Spread / Average Target
+9.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.73% | 52.26B | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B | |
| +24.30% | 31.41B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Transcript : Edwards Lifesciences Corporation - Shareholder/Analyst Call
